MORE►
OncoNano Medicine
Founders take the stage at MassChallenge’s flagship Innovate event in Dallas. [Photo: MassChallenge]
MassChallenge Makes Dallas Its Second U.S. Headquarters
by Sandra Engelland | Sep 30, 2026
Four years after arriving at Pegasus Park, the Boston-based accelerator is adding health and security accelerators and founder clinics, backed by a renewed two-year grant from Lyda Hill Philanthropies.
by Sandra Engelland |
Nov 20, 2025
With more than two decades of experience in product development, strategic operations, and commercial execution across the biotechnology industry, Brent Sorrells will help drive OncoNano’s next phase of growth and operational excellence, the company said.
MORE►
by Nicole Ward, DRC Data Journalist |
Jun 8, 2023
Elina Lavit, originally from the Soviet Union, charted a new course in 2021. Swapping San Francisco for Dallas, she's now steering business development at OncoNano Medicine, a North Texas biotech that aims to revolutionize cancer treatment.
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
OncoNano CEO Martin Driscoll [Photo: OncoNano]
Southlake Biotech OncoNano Medicine Raises $50M in Series B to Accelerate Cancer Tech Toward Commercialization
by Alex Edwards | Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE►
